Deutsche Bank Ag\ Soleno Therapeutics Inc Transaction History

Deutsche Bank Ag\

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$0.97 - $1.32 $41,434 - $56,385	-42,716 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$1.24 - $3.3 $4,498 - $11,972	-3,628 Reduced 7.83%	42,716 $53,000
Q4 2020 Feb 16, 2021	BUY	$1.61 - $2.23 $20,186 - $27,959	12,538 Added 37.09%	46,344 $90,000
Q3 2020 Nov 12, 2020	BUY	$1.71 - $2.51 $31,482 - $46,211	18,411 Added 119.59%	33,806 $85,000
Q2 2020 Aug 13, 2020	BUY	$1.77 - $4.23 $27,249 - $65,120	15,395 New	15,395 $34,000
Q4 2019 Feb 14, 2020	SELL	$1.35 - $2.95 $6,466 - $14,130	-4,790 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$1.5 - $2.99 $1,680 - $3,348	-1,120 Reduced 18.95%	4,790 $7,000
Q2 2019 Aug 14, 2019	SELL	$1.93 - $2.95 $54,985 - $84,045	-28,490 Reduced 82.82%	5,910 $16,000
Q1 2019 May 15, 2019	BUY	$1.35 - $2.68 $46,440 - $92,192	34,400 New	34,400 $70,000
Q4 2018 Feb 14, 2019	SELL	$1.55 - $2.3 $66 - $98	-43 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.95 - $3.07 $10,851 - $17,084	-5,565 Reduced 99.23%	43 $0
Q2 2018 Aug 14, 2018	BUY	$1.56 - $3.1 $8,748 - $17,384	5,608 New	5,608 $13,000

Ticker SLNO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 8,101,250
Market Cap $413M
Description
Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead candidate is Diazoxide Choline Controlled-Release, a once-daily oral tablet for the treatment of Prader-Willi Syndrome, which is being evaluated in an ongoing P...

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

Stay updated on Deutsche Bank Ag\ with notifications on news.